NCT01871220

Brief Summary

The purpose of this study is to compare the effect of two different implant abutment designs on gum tissue volume changes over time after implant placement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 3, 2013

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 6, 2013

Completed
7 months until next milestone

Study Start

First participant enrolled

December 30, 2013

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2018

Completed
3.7 years until next milestone

Results Posted

Study results publicly available

June 14, 2022

Completed
Last Updated

June 14, 2022

Status Verified

May 1, 2022

Enrollment Period

4.8 years

First QC Date

June 3, 2013

Results QC Date

January 2, 2022

Last Update Submit

May 19, 2022

Conditions

Keywords

Implant AbutmentsOral Mucosa ChangesImplant Esthetics

Outcome Measures

Primary Outcomes (1)

  • Peri-Implant Mucosal Zenith Distance (in Millimeters) at the Concave/Divergent Abutment Sites

    Determine if there is a difference in soft tissue peri-implant zenith changes (in millimeters) for the concave/divergent abutment sites, specifically between at delivery and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery. This measurement is taken using a standardized stereotactic digital photography system that allows for increased measurement accuracy and precision, specifically with the Canfield Dental Camera, Canfield Imaging Systems.

    Delivery, and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

Secondary Outcomes (2)

  • Submarginal Buccal-lingual Thickness (Millimeters) in the Peri-implant Transition Zone Relative to a Fixed Reference Point After Prosthesis Delivery

    Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

  • Keratinized Mucosa Width (Millimeters) at the Midfacial Aspect of the Implant Site.

    Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery

Study Arms (2)

Divergent Abutment

ACTIVE COMPARATOR

Divergent Transition Profile

Device: Divergent Transition Profile

Concave Abutment

EXPERIMENTAL

Concave Transition Profile

Device: Concave Transition Profile

Interventions

An Atlantis abutment is delivered with a concave transition profile.

Concave Abutment

An Atlantis abutment is delivered with a linear transition profile

Divergent Abutment

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or greater
  • Subjects requiring replacement of a single-rooted tooth in the maxillary arch from first premolar to first premolar with an implant-supported restoration
  • Teeth adjacent (mesial and distal) to study site must consist of two stable, natural teeth without signs of periodontal bone loss (\<2.0mm) and/or significant soft tissue loss
  • An opposing dentition with teeth, implants, or fixed prosthesis
  • Subjects must be willing to follow instructions related to the study procedures
  • Subjects must have read, understood, and signed the informed consent document

You may not qualify if:

  • Insufficient interocclusal space for implant placement and/or restoration at study site
  • More than 2.0mm vertical bone loss at study site as measured from the mid-buccal crest of the bone on the adjacent teeth
  • Untreated rampant caries
  • Tobacco use free for ≤ 6 months
  • Liver or kidney disfunction/failure
  • Active severe infectious diseases that may affect normal healing and/or bone metabolism (e.g. AIDS)
  • Uncontrolled diabetes
  • Current alcohol or drug abuse
  • Need for systemic corticosteroids or any other medication that would influence post-operative healing and/or osseointegration
  • History of relevant head/neck cancer and/or radiation of the head/neck
  • Subjects who currently use bisphosphonates or have a history of bisphosphonate use
  • Subjects with metabolic bone diseases such as osteoporosis or Paget's disease of bone
  • Known pregnancy or nursing mothers
  • Unable or unwilling to return for follow-up visits for a period of 1 year
  • Unlikely to be able to comply with study procedures according to investigators judgement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa College of Dentistry

Iowa City, Iowa, 52242, United States

Location

Results Point of Contact

Title
Dr. Christopher Barwacz
Organization
University of Iowa College of Dentistry

Study Officials

  • Christopher A Barwacz, DDS

    University of Iowa

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 3, 2013

First Posted

June 6, 2013

Study Start

December 30, 2013

Primary Completion

October 3, 2018

Study Completion

October 3, 2018

Last Updated

June 14, 2022

Results First Posted

June 14, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations